IMMUNE-INDUCING AGENT Russian patent published in 2020 - IPC A61K38/17 A61K35/76 A61P37/04 

FIELD: medicine.

SUBSTANCE: presented is an immune-inducing agent containing as an active ingredient at least one polypeptide having an immuno-inducing activity, or a recombinant vector containing a polynucleotide, which encodes a polypeptide and is able to express said polypeptide in vivo. Disclosed is a method of producing an antigen-presenting cell comprising a complex of said polypeptide and MHC molecules, involving bringing said polypeptide into contact with an antigen-presenting cell of an individual ex vivo or in vitro. What is presented is a method for producing a cytotoxic T-cell specific for said polypeptide. Disclosed is a method of inducing immunity, comprising administering to an individual at least one polypeptide having an immuno-inducing activity or a recombinant vector containing a polynucleotide encoding a polypeptide, and capable of expressing said polypeptide in vivo.

EFFECT: presented group of inventions provides effective agents and methods for inducing immunity.

11 cl, 2 ex, 3 dwg